AM Pharma 
Welcome,         Profile    Billing    Logout  
 2 Products   22 Diseases  2 Products   1 Trial   26 News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant human alkaline phosphatase intravenous (recAP) / AM Pharma
2019-004625-24: Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated Acute Kidney Injury

Not yet recruiting
3
1600
Europe, RoW
Recombinant Human Alkaline Phosphatase, recAP, Solution for infusion
AM-Pharma B.V., AM-Pharma B.V.
Sepsis-associated acute kidney injury, Sepsis-associated acute kidney injury, Body processes [G] - Immune system processes [G12]
 
 
NCT05890794: Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Completed
1/2
12
Europe
Ilofotase Alfa, 0.8 mg/kg, recAP, Ilofotase Alfa, 3.2 mg/kg
AM-Pharma
Hypophosphatasia
07/23
07/23
bovine alkaline phosphatase / AM Pharma, Liminal BioSci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant human alkaline phosphatase intravenous (recAP) / AM Pharma
2019-004625-24: Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated Acute Kidney Injury

Not yet recruiting
3
1600
Europe, RoW
Recombinant Human Alkaline Phosphatase, recAP, Solution for infusion
AM-Pharma B.V., AM-Pharma B.V.
Sepsis-associated acute kidney injury, Sepsis-associated acute kidney injury, Body processes [G] - Immune system processes [G12]
 
 
NCT05890794: Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Completed
1/2
12
Europe
Ilofotase Alfa, 0.8 mg/kg, recAP, Ilofotase Alfa, 3.2 mg/kg
AM-Pharma
Hypophosphatasia
07/23
07/23
bovine alkaline phosphatase / AM Pharma, Liminal BioSci
No trials found

Download Options